Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis

AB0297 Dose reduction in patients with rheumatoid arthritis responding to the standard rituximab regimen.

(2014) A. Batticciotto et al.   ANNALS OF THE RHEUMATIC DISEASES

Statistical review: frequently given comments

(2014) Stian Lydersen   ANNALS OF THE RHEUMATIC DISEASES

Choosing the Right Rituximab Dose for the Right Patient: Comment on the Article by Bredemeier et al

(2014) Edward M. Vital et al.   ARTHRITIS CARE & RESEARCH

Reply

(2014) Markus Bredemeier   ARTHRITIS CARE & RESEARCH

Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial

(2013) Xavier Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

(2013) Markus Bredemeier et al.   ARTHRITIS CARE & RESEARCH

Last observation carried forward approach threatens the validity of intent-to-treat analysis in fibromyalgia trials: Comment on the article by Arnold et al

(2012) Markus Bredemeier   ARTHRITIS AND RHEUMATISM

Beyond Repeated-Measures Analysis of Variance

(2012) Yan Ma et al.   REGIONAL ANESTHESIA AND PAIN MEDICINE

Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE

(2011) Paul P Tak et al.   ANNALS OF THE RHEUMATIC DISEASES

B-cell therapies in established rheumatoid arthritis

(2011) Maria J. Leandro et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

(2010) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)

(2010) A. Rubbert-Roth et al.   RHEUMATOLOGY